We are live on ! Find out more
FTRE icon

Fortrea Holdings

Positive
Neutral
Negative
Sentiment 3-Months
Positive 25%
Neutral 75%
Negative 0%

Neutral
GlobeNewsWire
5 days ago
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026.
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
Neutral
Zacks Investment Research
9 days ago
Stocks Look Shaky, But This Sector is Booming (Biotech)
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.
Stocks Look Shaky, But This Sector is Booming (Biotech)
Neutral
Zacks Investment Research
11 days ago
FTRE or ARGX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for their buck right now?
FTRE or ARGX: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
11 days ago
New Strong Buy Stocks for July 7th
DEC, FTRE, HG, PARR and KE have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2026.
New Strong Buy Stocks for July 7th
Neutral
GlobeNewsWire
22 days ago
Fortrea Names Jason Knoblauch as Chief Financial Officer
Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea
Fortrea Names Jason Knoblauch as Chief Financial Officer
Neutral
GlobeNewsWire
1 month ago
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the granting of an inducement award of restricted stock units (“RSUs”) on June 10, 2026, to 10 newly hired employees. The award consisted of 240,500 RSUs that vest in three equal annual installments starting June 10, 2027, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Neutral
GlobeNewsWire
1 month ago
Fortrea to Attend Jefferies Global Healthcare Conference
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference:
Fortrea to Attend Jefferies Global Healthcare Conference
Neutral
Seeking Alpha
2 months ago
Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago.
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Neutral
GlobeNewsWire
2 months ago
Fortrea Reports First Quarter 2026 Results
Strong first-quarter performance reinforces confidence in FY 2026 guidance Book-to-bill of 1.15x is third consecutive quarter above 1.1x
Fortrea Reports First Quarter 2026 Results